Twin Tree Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-700
Closed -$8.28K 1873
2024
Q4
$8.28K Sell
700
-192,900
-100% -$2.28M ﹤0.01% 1507
2024
Q3
$2.23M Sell
193,600
-65,000
-25% -$740K ﹤0.01% 1099
2024
Q2
$2.73M Buy
258,600
+189,100
+272% +$2.07M 0.01% 896
2024
Q1
$733K Sell
69,500
-701,700
-91% -$7.57M ﹤0.01% 1085
2023
Q4
$8.66M Buy
+771,200
New +$7.52M 0.02% 727

Other funds holding ROIV

Twin Tree Management's ROIV Position: Q1 2025 in Review

Twin Tree Management sold out of Roivant Sciences (ROIV) in Q1 2025, closing a stake of 48 shares — an estimated $519 sold.

Twin Tree Management first reported a position in ROIV in Q4 2023 and held it in 4 quarters. The position peaked at $826K in Q2 2024. 312 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • Twin Tree Management reported no remaining Roivant Sciences position as of Q1 2025 after selling out during the quarter.
  • Twin Tree Management sold 48 Roivant Sciences shares in Q1 2025, an estimated $519.
  • Twin Tree Management first reported a position in Roivant Sciences in Q4 2023 and held it in 4 quarters.
  • Twin Tree Management's Roivant Sciences position peaked at $826K in Q2 2024.
  • 312 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on Twin Tree Management's 13F filing for Q1 2025, filed 15 May 2025.